NovoCure Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio889.29
P/S Ratio5.333.1314.3114.5735.63
P/B Ratio8.954.4017.4518.9936.97
Price/Tangible Book8.954.4017.4518.9936.97
Price/FCF816.34133.05209.25
Price/OCF250.0394.19177.66
PEG Ratio7.19
Enterprise Value Ratios
EV/Revenue4.862.4813.5913.8935.18
EV/EBITDA451.06
EV/EBIT564.54
EV/FCF774.90126.89206.62
Profitability & Returns
Return on Equity (ROE)-0.47%-0.52%-0.22%-0.13%0.06%
Return on Assets (ROA)-0.09%-0.12%-0.05%-0.02%0.03%
Return on Capital Employed (ROCE)-0.35%-0.23%-0.09%-0.04%0.03%
Leverage & Solvency Ratios
Debt/Equity1.901.651.321.400.93
Debt/EBITDA9.98
Debt/FCF61.979.825.28
Liquidity Ratios
Current Ratio1.465.787.007.538.80
Quick Ratio1.375.466.737.298.38
Efficiency Ratios
Asset Turnover0.510.440.460.490.65
Inventory Turnover3.723.784.254.414.15
Yield & Distribution Ratios
Earnings Yield-0.05%-0.13%-0.01%-0.01%0.00%
FCF Yield-0.02%-0.06%0.00%0.01%0.00%
Buyback Yield-0.01%-0.02%-0.01%0.05%-0.12%